DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0038013 | Ankylosing spondylitis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0003467 | Anxiety | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0035579 | Rickets | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0392525 | Nephrolithiasis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0022658 | Kidney Diseases | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0033300 | Progeria | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0234533 | Generalized seizures | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0022333 | Jacksonian Seizure | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0270824 | Visual seizure | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0004096 | Asthma | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0020503 | Hyperparathyroidism, Secondary | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0025521 | Inborn Errors of Metabolism | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0002871 | Anemia | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0340076 | Asthmatic pulmonary eosinophilia | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0011581 | Depressive disorder | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0020492 | Hyperostosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C1956346 | Coronary Artery Disease | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0020437 | Hypercalcemia | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0029463 | Osteosarcoma | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0015300 | Exophthalmos | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0027709 | Nephrocalcinosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C1859722 | Arthrogryposis, renal dysfunction, and cholestasis 1 | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C1306459 | Primary malignant neoplasm | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0003469 | Anxiety Disorders | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024